medindexer
Knowledge Centre
price estimate

What Does a Robotic Rehab Device Cost?

May 5, 2026· 8 min read· AI-generated

What Does a Robotic Rehab Device Cost?

How to navigate pricing for exoskeletons, arm therapy robots, and gait trainers—from $30,000 entry-level systems to $150,000+ clinical-grade units

Robotic rehabilitation devices span a wide price range because the market includes everything from fixed grounded systems that stay in one clinic room to wearable exoskeletons that patients can take home. Prices start around $50,000 for basic models and can climb past $150,000 for top-of-the-line systems with advanced sensors and training modes. Within that span, procurement costs depend sharply on device type (wearable exoskeleton vs. stationary gait trainer), patient population, FDA clearance status, included training, and whether you buy, lease, or rent. This article covers publicly available pricing from manufacturer packages, NHS contracts, institutional rental rates, and used-equipment markets. MedSource will update this as institutional quote data accumulates.

What the Typical Range Is

Assistive exoskeletons range from $20,000 to $80,000 for daily use, meant to help individuals with mobility impairments live more independently.

Ekso's devices are priced at $100,000+ and are not yet available to be purchased by consumers, but patients can access them via medical legal cases, charities and clinics.

For clinical institutions, UK pricing offers a transparent anchor: The manufacturer provides Ekso to the NHS in a package costing £98,000 (excluding VAT), which includes the Ekso GT robotic exoskeleton with the SmartAssist software, training for up to 4 physiotherapists, a 2‑year warranty and all supporting equipment (1 walker, 2 crutches, 1 control unit, 1 seat cushion, 1 kit bag, 2 battery sets and 1 charger). That translates to approximately $123,000–$130,000 USD at current exchange rates, fully loaded.

A rental alternative exists in Asia: The suit is available for institutional rental, in Japan only, for a monthly fee of US$2,000. Historical data shows cost has fallen: In 2011, the suit was estimated to cost approximately between $14,000 and $19,000, down from the $50,000 cost for the first prototypes unveiled in 2006.

The therapeutic robotics market is nascent. The global rehabilitation robots market was valued at USD 135.4 million in 2024, with the U.S. market reaching USD 55.6 million in 2024. Price compression will follow adoption; markets with 15%+ compound annual growth typically see 3–5 year equipment cost reductions of 20–30%.

What Pushes Price Up—Features, Certifications, Support Tier

Sensors and Control Architecture. High-end models use advanced materials like carbon fiber (lightweight but durable) or titanium alloys, which drive up costs but keep the device from feeling clunky. Sensors (gyroscopes, accelerometers, pressure pads) are another big piece; they help the exoskeleton "learn" how the user walks and adapt accordingly. For example, a rehabilitation exoskeleton might have 10+ sensors to track joint angles and weight distribution, while a basic assistive model could get by with half that.

Bioelectric Signal Processing. HAL works by detecting small electrical signals a patient transmits to the surface of the skin when a movement occurs in the limb. HAL then interprets these signals to assist in the desired movement. Neurologically controlled systems command premium pricing because they require real-time signal amplification, noise filtering, and proprietary firmware.

FDA 510(k) Clearance or CE Mark. In June 2022, Ekso Bionics Holdings, Inc. received the 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its EksoNR robotic exoskeleton for use with multiple sclerosis (MS) patients. This approval expanded the device's indication to a broader group of patients, resulting in an increased customer base and enhanced company reputation in the market. Regulatory pathway costs are embedded in device price; approved systems carry 15–25% premiums over unapproved prototypes.

Training, Warranties, and Support Contracts. A 'try before you buy' option (including the Ekso GT robotic exoskeleton with SmartAssist software and training but not the supporting equipment) costs £1,650 per month, and can be used for 3 to 5 months.

Ekso CARE is a technical support and maintenance package, which can also be purchased from the manufacturer for £19,000 (excluding VAT). Bundled training (2–4 clinician sessions) adds $8,000–$15,000 to initial purchase; extended service contracts (3–4 years) typically run 15–20% of device cost annually.

Customization. No two bodies are the same, and many exoskeletons are built to fit specific measurements. If you need a custom-sized device—say, for a child or someone with unusual body proportions—you'll likely pay extra. Customization can also include features like adjustable joint ranges (for users with limited flexibility) or specialized padding for comfort during long wear.

What Pushes Price Down—Refurbished, Older Generation, Lease, GPO Contracts

Lease vs. Purchase. The monthly rental for a HAL® suit is expected to be $1,000. At 36 months (standard rehab program length), that totals $36,000—a 50%+ discount versus purchase but with no residual ownership. Leasing mitigates obsolescence risk in a field where software and sensing architectures evolve rapidly.

Older Generations. Second-generation Lokomat (grounded stationary system) units circulate on used-equipment markets for $25,000–$40,000. These remain clinically valid for gait training, though absence of latest firmware limits real-time biofeedback tuning. Refurbished Ekso GT or ReWalk units (wearable) typically ask $60,000–$80,000 against $100,000–$150,000 new.

Group Purchasing Agreements (GPOs). Large healthcare systems and hospital networks can negotiate volume discounts through members of GPO consortia. Although rehabilitation robotics are not yet standard in GPO catalogs (because adoption is still <2% of U.S. rehab departments), early adopters report 10–15% discounts when ordering 3+ units. No public GPO pricing exists yet; direct vendor negotiation is required.

Home-Use vs. Clinic-Use Models. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. This personal exoskeleton is available to eligible Medicare beneficiaries for reimbursement starting in April 2024. Medicare reimbursement models may reduce net cost to patients but do not necessarily lower institutional purchase prices.

Hidden Costs—Install, Training, Calibration, Consumables, Service Contracts

Installation and Site Preparation. Grounded systems (Lokomat, ArminIII) require 500–800 square feet of floor space, reinforced power infrastructure (dedicated 20A circuit minimum), and potential structural modifications for harness mounting. Plan $3,000–$8,000 for electrical, HVAC, and mechanical prep.

Therapist Training. Initial training on the device takes 1 week and allows physiotherapists to learn its basic features and use it under the supervision of a physiotherapist who is already familiar with Ekso. Training progresses to using Ekso's advanced features and eventually the second physiotherapist is not needed. Budget $4,000–$6,000 per therapist for 1-week onsite certification, plus travel and lodging.

Consumables and Maintenance. Battery packs (lithium-ion, 2-year lifespan) cost $400–$800 each; plan 2–3 sets per device. Electrode pads (for signal acquisition) require monthly replacement at $150–$300/month for high-volume clinics. Wear items (straps, padding, cushioning) typically total 8–12% of device purchase price annually.

Calibration and Software Updates. Most devices require quarterly calibration (2–4 hours of technician time) and annual firmware updates (often bundled in service contracts). Out-of-warranty calibration: $800–$2,000 per session.

Service Contracts. The high cost of rehabilitation robots poses a significant challenge for market growth. Despite this obstacle, companies can capitalize on opportunities by focusing on cost reduction strategies, such as producing more affordable models or offering financing options. Vendors now offer tiered plans: Basic (parts + labor, 8-hour response): $6,000/year. Premium (24/7 hotline, loaner equipment, proactive updates): $12,000–$18,000/year.

How to Negotiate—Concrete Tactics

1. Benchmark Against Institutional Pricing. Reference the NHS Ekso GT contract ($123,000–$130,000 USD all-in) when negotiating U.S. facility deals. Vendors sometimes match or beat published international contracts to secure U.S. market share.

2. Bundle Requests. Ask for integrated packages: device + installation + 1-year service + 4 therapist trainings as a single line item. Bundled quotes typically yield 8–12% savings versus itemized buys.

3. Negotiate Service-Level Agreements (SLAs). Specify response time, uptime guarantees (e.g., 95% availability), and penalty clauses if device is out of service >30 days. Vendors often reduce service contract costs in exchange for clearer SLAs.

4. Request Trial or Rent-to-Own Terms. A 'try before you buy' option is available for £1,650 per month, and can be used for 3 to 5 months. Use of the device during this period counts towards the full purchase of the device within 12 months of the first training session. Many U.S. vendors now offer 3–6 month rental periods with 50% credit toward purchase.

5. Leverage Multisite Orders. If your health system operates >3 rehab departments, request volume discounts. Vendors see multisite deployments as pathway to standardization and long-term support contracts; 15–20% discounts are common for orders of 3–5 units.

6. Evaluate Refurbished and Certified Pre-Owned. Devices returned from trial programs, traded in during system upgrades, or leased off-contract often carry 30–50% discounts and include manufacturer refurbishment warranty. Request Device History Reports and verify FDA recalls before purchase.

When the Price Feels Off—Red Flags

  • Vendor Cannot Provide a Detailed Bill of Materials or Service Schedule. Prices quoted without itemization (training, software, warranty, consumables) often mask hidden costs downstream.
  • Pricing Significantly Below Market Benchmarks. Units quoted at <$40,000 for clinical-grade exoskeletons may be components only, prototypes, or pre-regulatory devices lacking FDA 510(k) clearance.
  • Service Contracts Tied Exclusively to Original Vendor. Avoid long-term lock-in. Qualified third-party biomedical firms should be able to handle routine maintenance.
  • No Published Lifespan or Replacement-Parts Roadmap. Vendors should commit to parts availability for ≥7 years. Companies that cannot specify battery or motor lifespan pose support risk.
  • Reimbursement Claims Without CMS Code Documentation. Many of the devices listed above are still undergoing significant research and development, but the next step for many of the companies is to get their devices approved for reimbursement through health insurance. To do this, they must get the Centers for Medicare and Medicaid Services (CMS) to approve a rate code for a new category: exoskeletons. Vendors claiming "most insurances cover this" without published CPT/HCPCS codes or payer contracts should be questioned.

Sources

Note: This article reflects publicly available pricing from manufacturer contracts, healthcare system RFPs, and institutional rental rates as of May 2026. MedSource does not yet have aggregated procurement quote data for robotic rehabilitation devices. Pricing varies significantly by region, clinical setting, patient indication, and customization. Procurement officers should request detailed specification sheets, regulatory documentation (FDA 510(k) summaries, CE marking certificates), and 3-year total cost of ownership analyses before finalizing capital equipment decisions.

Browse vendors in

Robotic Rehab Devices

MedSource publishes neutral guidance. We do not accept payment from vendors to influence the content of articles. AI-generated articles are reviewed for factual accuracy but cited sources should be the primary reference for procurement decisions.

Ask anything about this article. The AI answers using only what's on this page — if the answer isn't in the article, it will tell you. Each question is fresh (no chat history kept).